信息搜索
信息关键字：药
  

共有5342条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268]

·昆药集团：九届一次董事会决议公告2018-11-3 0:46:14
·科伦药业拟斥资0.5亿至1亿元回购公司股份2018-11-2 21:36:31
·仁堂医药拟3600万元收购元延医药17.68%股份2018-11-2 21:07:31
·国药集团副总经理：创新能力和环保压力考验药企战略定位和耐力2018-11-2 20:54:48
·博济医药：股东达晨创世及达晨盛世拟合计减持不超3%股份2018-11-2 20:29:44
·博济医药两股东拟合计减持不超3%股份2018-11-2 20:08:45
·药明康德：参股公司在美挂牌上市公司持有0.546%股份2018-11-2 16:38:18
·以岭药业：全资子公司获得《药品GMP证书》2018-11-2 16:21:35
·亚宝药业：已回购近6500万元股份2018-11-2 16:00:57
·研发创新驱动行业发展医药板块高景气持续(附股)2018-11-2 15:06:04
·中国医药：积极应对“两票制”政策致经营性现金净流出较多2018-11-2 11:29:34
·东阳光科控股股东宜昌东阳光药业质押3000万股用于融资担保2018-11-2 11:20:38
·医药生物板块表现强势宜华健康涨停2018-11-2 11:16:12
·岭南集团与广药集团达成战略合作岭南控股或迎利好2018-11-2 10:26:02
·环球药业新三板募资1225万元副总经理常世忠认购75万元2018-11-2 9:27:53
·紫鑫药业业绩暴增笼52亿存货阴影财务造假疑云缭绕2018-11-2 8:24:43
·汇群中药副总经理陈桂萍辞职持有公司0.46%股份2018-11-2 7:51:36
·云南白药508亿吸收合并白药控股实现集团整体上市2018-11-2 3:40:20
·云南白药吸收合并白药控股2018-11-2 3:11:13
·牵手华润医药拓展终端市场以岭药业前三季业绩稳增2018-11-2 1:43:24

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268]